Cargando…
High‐Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long‐Term Outcomes
BACKGROUND: The associations between high‐sensitivity troponin I (hsTnI) levels and coronary artery disease (CAD) severity and progression remain unclear. We investigated whether there is an association between hsTnI and angiographic severity and progression of CAD and whether the predictive value o...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866331/ https://www.ncbi.nlm.nih.gov/pubmed/29467150 http://dx.doi.org/10.1161/JAHA.117.007914 |
_version_ | 1783308828603842560 |
---|---|
author | Samman Tahhan, Ayman Sandesara, Pratik Hayek, Salim S. Hammadah, Muhammad Alkhoder, Ayman Kelli, Heval M. Topel, Matthew O'Neal, Wesley T. Ghasemzadeh, Nima Ko, Yi‐An Gafeer, Mohamad Mazen Abdelhadi, Naser Choudhary, Fahad Patel, Keyur Beshiri, Agim Murtagh, Gillian Kim, Jonathan Wilson, Peter Shaw, Leslee Vaccarino, Viola Epstein, Stephen E. Sperling, Laurence Quyyumi, Arshed A. |
author_facet | Samman Tahhan, Ayman Sandesara, Pratik Hayek, Salim S. Hammadah, Muhammad Alkhoder, Ayman Kelli, Heval M. Topel, Matthew O'Neal, Wesley T. Ghasemzadeh, Nima Ko, Yi‐An Gafeer, Mohamad Mazen Abdelhadi, Naser Choudhary, Fahad Patel, Keyur Beshiri, Agim Murtagh, Gillian Kim, Jonathan Wilson, Peter Shaw, Leslee Vaccarino, Viola Epstein, Stephen E. Sperling, Laurence Quyyumi, Arshed A. |
author_sort | Samman Tahhan, Ayman |
collection | PubMed |
description | BACKGROUND: The associations between high‐sensitivity troponin I (hsTnI) levels and coronary artery disease (CAD) severity and progression remain unclear. We investigated whether there is an association between hsTnI and angiographic severity and progression of CAD and whether the predictive value of hsTnI level for incident cardiovascular outcomes is independent of CAD severity. METHODS AND RESULTS: In 3087 patients (aged 63±12 years, 64% men) undergoing cardiac catheterization without evidence of acute myocardial infarction, the severity of CAD was calculated by the number of major coronary arteries with ≥50% stenosis and the Gensini score. CAD progression was assessed in a subset of 717 patients who had undergone ≥2 coronary angiograms >3 months before enrollment. Patients were followed up for incident all‐cause mortality and incident cardiovascular events. Of the total population, 11% had normal angiograms, 23% had nonobstructive CAD, 20% had 1‐vessel CAD, 20% had 2‐vessel CAD, and 26% had 3‐vessel CAD. After adjusting for age, sex, race, body mass index, smoking, hypertension, diabetes mellitus history, and renal function, hsTnI levels were independently associated with the severity of CAD measured by the Gensini score (log 2 ß=0.31; 95% confidence interval, 0.18–0.44; P<0.001) and with CAD progression (log 2 ß=0.36; 95% confidence interval, 0.14–0.58; P=0.001). hsTnI level was also a significant predictor of incident death, cardiovascular death, myocardial infarction, revascularization, and cardiac hospitalizations, independent of the aforementioned covariates and CAD severity. CONCLUSIONS: Higher hsTnI levels are associated with the underlying burden of coronary atherosclerosis, more rapid progression of CAD, and higher risk of all‐cause mortality and incident cardiovascular events. Whether more aggressive treatment aimed at reducing hsTnI levels can modulate disease progression requires further investigation. |
format | Online Article Text |
id | pubmed-5866331 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58663312018-03-28 High‐Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long‐Term Outcomes Samman Tahhan, Ayman Sandesara, Pratik Hayek, Salim S. Hammadah, Muhammad Alkhoder, Ayman Kelli, Heval M. Topel, Matthew O'Neal, Wesley T. Ghasemzadeh, Nima Ko, Yi‐An Gafeer, Mohamad Mazen Abdelhadi, Naser Choudhary, Fahad Patel, Keyur Beshiri, Agim Murtagh, Gillian Kim, Jonathan Wilson, Peter Shaw, Leslee Vaccarino, Viola Epstein, Stephen E. Sperling, Laurence Quyyumi, Arshed A. J Am Heart Assoc Original Research BACKGROUND: The associations between high‐sensitivity troponin I (hsTnI) levels and coronary artery disease (CAD) severity and progression remain unclear. We investigated whether there is an association between hsTnI and angiographic severity and progression of CAD and whether the predictive value of hsTnI level for incident cardiovascular outcomes is independent of CAD severity. METHODS AND RESULTS: In 3087 patients (aged 63±12 years, 64% men) undergoing cardiac catheterization without evidence of acute myocardial infarction, the severity of CAD was calculated by the number of major coronary arteries with ≥50% stenosis and the Gensini score. CAD progression was assessed in a subset of 717 patients who had undergone ≥2 coronary angiograms >3 months before enrollment. Patients were followed up for incident all‐cause mortality and incident cardiovascular events. Of the total population, 11% had normal angiograms, 23% had nonobstructive CAD, 20% had 1‐vessel CAD, 20% had 2‐vessel CAD, and 26% had 3‐vessel CAD. After adjusting for age, sex, race, body mass index, smoking, hypertension, diabetes mellitus history, and renal function, hsTnI levels were independently associated with the severity of CAD measured by the Gensini score (log 2 ß=0.31; 95% confidence interval, 0.18–0.44; P<0.001) and with CAD progression (log 2 ß=0.36; 95% confidence interval, 0.14–0.58; P=0.001). hsTnI level was also a significant predictor of incident death, cardiovascular death, myocardial infarction, revascularization, and cardiac hospitalizations, independent of the aforementioned covariates and CAD severity. CONCLUSIONS: Higher hsTnI levels are associated with the underlying burden of coronary atherosclerosis, more rapid progression of CAD, and higher risk of all‐cause mortality and incident cardiovascular events. Whether more aggressive treatment aimed at reducing hsTnI levels can modulate disease progression requires further investigation. John Wiley and Sons Inc. 2018-02-21 /pmc/articles/PMC5866331/ /pubmed/29467150 http://dx.doi.org/10.1161/JAHA.117.007914 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Samman Tahhan, Ayman Sandesara, Pratik Hayek, Salim S. Hammadah, Muhammad Alkhoder, Ayman Kelli, Heval M. Topel, Matthew O'Neal, Wesley T. Ghasemzadeh, Nima Ko, Yi‐An Gafeer, Mohamad Mazen Abdelhadi, Naser Choudhary, Fahad Patel, Keyur Beshiri, Agim Murtagh, Gillian Kim, Jonathan Wilson, Peter Shaw, Leslee Vaccarino, Viola Epstein, Stephen E. Sperling, Laurence Quyyumi, Arshed A. High‐Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long‐Term Outcomes |
title | High‐Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long‐Term Outcomes |
title_full | High‐Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long‐Term Outcomes |
title_fullStr | High‐Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long‐Term Outcomes |
title_full_unstemmed | High‐Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long‐Term Outcomes |
title_short | High‐Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long‐Term Outcomes |
title_sort | high‐sensitivity troponin i levels and coronary artery disease severity, progression, and long‐term outcomes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866331/ https://www.ncbi.nlm.nih.gov/pubmed/29467150 http://dx.doi.org/10.1161/JAHA.117.007914 |
work_keys_str_mv | AT sammantahhanayman highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT sandesarapratik highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT hayeksalims highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT hammadahmuhammad highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT alkhoderayman highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT kellihevalm highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT topelmatthew highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT onealwesleyt highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT ghasemzadehnima highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT koyian highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT gafeermohamadmazen highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT abdelhadinaser highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT choudharyfahad highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT patelkeyur highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT beshiriagim highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT murtaghgillian highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT kimjonathan highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT wilsonpeter highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT shawleslee highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT vaccarinoviola highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT epsteinstephene highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT sperlinglaurence highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes AT quyyumiarsheda highsensitivitytroponinilevelsandcoronaryarterydiseaseseverityprogressionandlongtermoutcomes |